2022 Press Releases

January 12, 2022

Johnson & Johnson Medical Devices Companies Partners with Microsoft to Further Enable its Digital Surgery Solutions

Johnson & Johnson Medical Devices Companies (JJMDC)* has announced a partnership with Microsoft to enhance and grow JJMDC's secure and compliant digital surgery ecosystem. JJMDC will use the Microsoft Cloud to realise its objective of driving innovation that improves skills, workflow, and surgical decision-making for a better overall customer experience and better patient and economic outcomes.
 
Next-generation robotics, world-class instrumentation, advanced imaging and visualisation, data and analytics, artificial intelligence, machine learning, and digital solutions are all part of the JJMDC ecosystem. It is critical to establish robust connectivity with, and between, all elements of the ecosystem with a seamless, interconnected network that meets surgeons where they are in their workflow and patients where they are in their healthcare journey in order to unlock the potential of these assets and make a clinical difference for patients.
 
"Collaborating with Microsoft will help take our digital approach to the next level as we create a best-in-class, unified platform across our innovative surgical technologies," said Larry Jones, Group CIO and Global Vice President, Medical Devices, Johnson & Johnson. "It brings together our collective expertise and is an exciting step towards creating a connected patient journey across the entire care continuum, before, during, and after a procedure."
 
As part of the strategic partnership, Microsoft will serve as JJMDC's preferred cloud provider for the company's digital surgery solutions and help JJMDC build out its digital surgery platform and internet of things (IoT) device connectivity. By harnessing the power of the Microsoft Cloud, including Azure, artificial intelligence (AI), and machine learning, Microsoft 365 and Dynamics 365, the companies expect to work together to deliver innovation across the following areas:

  • Innovating to improve patient outcomes through artificial intelligence, machine learning and data insights.

  • Increasing JJMDC device connectivity, insights and intelligence using Azure IoT and Edge Computing technologies.

  • Increasing the pace of digital innovation and transformation across the JJMDC digital surgery ecosystem using Azure capabilities and services.

"At the Johnson & Johnson Medical Devices companies, we're shaping a future where medical intervention is smarter, less invasive, and more personalised," said Peter Schulam, MD, PhD, Global Head, Medical Affairs, Clinical Affairs and Pre-Clinical Research, Johnson & Johnson Medical Devices Companies, and Leader, Office of Digital Innovation. "We're excited to collaborate with Microsoft on this important work as we continue to expand our digital surgery assets and capabilities, develop innovative and advanced instrumentation, and make a meaningful clinical difference for customers and patients."